DAVID FLOWERS: Open Payments
NPI 1689715781 · GAHANNA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 19 payments from 12 companies in 2025. Trend: 2023 $327 · 2024 $124 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $84 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $39 |
| ABBVIE INC. | 2 | $35 |
| PFIZER INC. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $26 |
| Amgen Inc. | 1 | $22 |
| Medtronic, Inc. | 1 | $19 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: ZEPBOUND, Auvelity, Ozempic, Veozah, REPATHA, MOUNJARO, INCEPTIV, UBRELVY.
Industry payments across OH — which companies pay providers there.
